Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity
Clicks: 672
ID: 115448
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
75.3
/100
672 views
456 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #2 of 14 articles by views in the american journal of psychiatry
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Irritability is an important symptom domain of major depressive disorder that is not fully reflected in depressive symptom severity measures. Early reductions in irritability, when combined with changes in depressive symptom severity, provide a robust estimate of likelihood of remission or no meanin …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (43 words).
Try re-searching for a better abstract.
| Reference Key |
mk2019theirritability
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jha MK;Minhajuddin A;South C;Rush AJ;Trivedi MH;; |
| Journal | the american journal of psychiatry |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
logistic models
prognosis
treatment outcome
research support
non-u.s. gov't
adult
female
male
N.I.H.
Extramural
Depressive Disorder
Major / psychology
middle aged
randomized controlled trials as topic
severity of illness index
antidepressive agents / therapeutic use*
single-blind method
pmid:30922100
doi:10.1176/appi.ajp.2018.18030355
manish k jha
abu minhajuddin
madhukar h trivedi
ambulatory care
bupropion / therapeutic use
citalopram / therapeutic use
major / drug therapy*
irritable mood*
mirtazapine / therapeutic use
venlafaxine hydrochloride / therapeutic use
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.